Reliability of Drug Utilization Evaluation as an Assessment of Medication Appropriateness
- 1 May 1997
- journal article
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 31 (5), 533-542
- https://doi.org/10.1177/106002809703100502
Abstract
OBJECTIVE: To test the reliability of drug utilization evaluation (DUE) applied to medications commonly used by the ambulatory elderly. METHODS: A DUE model was developed for four domains: (1) justification for use, (2) critical process indicators, (3) complications, and (4) clinical outcomes. DUE criteria specific to use in the elderly were developed for angiotensin-converting enzyme (ACE) inhibitors and histamine2 (H2)-antagonists, and consensus was reached by an external expert panel. After pilot testing, two clinical pharmacists independently evaluated these medications, applying the DUE criteria and rating each item as appropriate or inappropriate. Interrater and intrarater reliability was assessed by using κ statistics. RESULTS: In a sample of 208 ambulatory elderly veterans, 42 (20.2%) were taking an ACE inhibitor and 56 (26.9%) an H2-antagonist. The interrater agreement for individual domains, represented by κ statistics, were 0.10–0.58 and 0–0.83 for ACE inhibitors and H2-antagonists, respectively. The κ statistic for overall agreement, which considered ratings from all criteria across all domains, was 0.24 for ACE inhibitors and 0.18 for H2-antagonists. Intrarater reliability was assessed 3 months later, and κ statistics were 0.61–0.65 (0.49 overall) and 0–0.96 (0.81 overall) for ACE inhibitors and H2-antagonists, respectively. CONCLUSIONS: Intrarater reliability for DUE was good to excellent. However, interrater reliability exhibited only marginal reproducibility, particularly where evaluators were required to use subjective judgment (i.e., complications, clinical outcomes). DUE may not be a suitable standard for assessing medication appropriateness in ambulatory elderly patients.Keywords
This publication has 18 references indexed in Scilit:
- Appropriateness of therapy with angiotensin-converting-enzyme inhibitors in elderly outpatientsAmerican Journal of Health-System Pharmacy, 1996
- Adverse Events Related to Drugs and Drug Withdrawal in Nursing Home ResidentsJournal of the American Geriatrics Society, 1993
- Drug Utilization Review in Ambulatory Settings: State of the Science and Directions for Outcomes ResearchMedical Care, 1993
- Inappropriate Medication Prescribing in Skilled-Nursing FacilitiesAnnals of Internal Medicine, 1992
- Applied TherapeuticsPublished by Springer Science and Business Media LLC ,1992
- Panel I. Drug utilization review: Criteria*Clinical Pharmacology & Therapeutics, 1991
- Drug utilization review: State of the art from an academic perspectiveClinical Pharmacology & Therapeutics, 1991
- Development of criteria for drug utilization reviewClinical Pharmacology & Therapeutics, 1991
- Drug Utilization Study Methodologies: National and International PerspectivesDrug Intelligence & Clinical Pharmacy, 1987
- Cimetidine Use in Nursing Homes: Prolonged Therapy and Excessive DosesJournal of the American Geriatrics Society, 1987